Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated May 28, 2019 (7 years ago)

Sn-DTPA Kit 10 mg

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Processing Controls.

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

Sn-DTPA Kit 10 mg, DTPA, Not for Direct Injection, Store at Room Temperature, Synthetopes, Inc.

Recalling firm
Synthetopes Inc
Origin
SC, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1404-2019 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Synthetopes Inc

All 2019 recalls
Class II · Moderate risk

Sn-d

Lack of Processing Controls.

Terminated cGMP deviation Synthetopes Inc D-1403-2019

Other cgmp deviation recalls from 2019

All cgmp deviation recalls
Class II · Moderate risk

Yeast Arrest

cGMP violations

Terminated cGMP deviation Wisconsin Pharmacal Company, LLC NDC 68093-0730-1 D-0781-2020